Status:

UNKNOWN

Lung Ultrasound as a Point of Care Test for Living Donor Liver Transplant Recipients.

Lead Sponsor:

Institute of Liver and Biliary Sciences, India

Conditions:

Liver Transplant; Complications

Eligibility:

All Genders

18-65 years

Brief Summary

Liver transplant is now a standard treatment for end-stage liver disease patients. Pulmonary complications are common in the perioperative period and are associated with adverse outcomes. This include...

Detailed Description

This is a prospective observational study on liver transplant recipient patients, until postoperative day seven. After approval of the ethical committee and written informed consent, all liver transpl...

Eligibility Criteria

Inclusion

  • Age 18 to 65yrs All end stage liver disease patients undergoing live donor liver transplantation

Exclusion

  • Patients not giving consent for enrollment Any structural cardiac condition Dead donor liver transplant

Key Trial Info

Start Date :

November 11 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 25 2021

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04413695

Start Date

November 11 2019

End Date

September 25 2021

Last Update

October 5 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gaurav Sindwani

New Delhi, National Capital Territory of Delhi, India, 110070